| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EDIT | Editas Medicine, Inc. | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Feb 13, 2023 | Sale | $9.67 | 2,790 | 26,966 | 65,559 | Feb 15, 2023, 04:30 PM | |
| EDIT | Editas Medicine, Inc. | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Jun 15, 2022 | Sale | $10.06 | 5,145 | 51,745 | 68,349 | Jun 16, 2022, 04:15 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Shearman Mark S | Chief Scientific Officer | Aug 15, 2020 | Option Exercise | $5.77 | 5,723 | 33,022 | 33,277 | Aug 18, 2020, 06:15 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Shearman Mark S | Chief Scientific Officer | Dec 14, 2018 | Sale | $3.35 | 3,000 | 10,053 | 0 | Dec 18, 2018, 07:58 PM | |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Shearman Mark S | Chief Scientific Officer | Sep 22, 2016 | Buy | $8.87 | 3,000 | 26,601 | 3,000 | Sep 26, 2016, 05:20 PM |
Menu